Cargando…

Comparison of Insulin-Treated Patients with Ambiguous Diabetes Type with Definite Type 1 and Type 2 Diabetes Mellitus Subjects: A Clinical Perspective

In clinical practice, the distinction between type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) can be challenging, leaving patients with “ambiguous” diabetes type. Insulin-treated patients (n=115) previously diagnosed with T2DM had to be re-classified based on clinical phenotype a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laspe, Insa, Meier, Juris J., Nauck, Michael A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Diabetes Association 2023
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925152/ https://www.ncbi.nlm.nih.gov/pubmed/35313393 http://dx.doi.org/10.4093/dmj.2021.0322

Ejemplares similares

Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus
por: Mader, Julia K., et al.
Publicado: (2016)

Prevalence of depressive symptoms among non insulin treated Greek type 2 diabetic subjects
por: Sotiropoulos, Alexios, et al.
Publicado: (2008)

Is the Diminished Incretin Effect in Type 2 Diabetes Just an Epi-Phenomenon of Impaired β-Cell Function?
por: Meier, Juris J., et al.
Publicado: (2010)

Chronic Reduction of Fasting Glycemia With Insulin Glargine Improves First- and Second-Phase Insulin Secretion in Patients With Type 2 Diabetes
por: Pennartz, Christian, et al.
Publicado: (2011)

GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
por: Nauck, Michael A., et al.
Publicado: (2020)

Statistical power for MACE and individual secondary endpoints in cardiovascular outcomes trials for type 2 diabetes: a systematic review
por: Birker, Sebastian, et al.
Publicado: (2022)

Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes
por: Thomas, Nicholas J., et al.
Publicado: (2019)

Insulin-induced Lipohypertrophy in Patients with Type 1 Diabetes Mellitus Treated with an Insulin Pump
por: Ucieklak, Damian, et al.
Publicado: (2022)

Risk factors associated with diabetic retinopathy in patients with diabetes mellitus type 2
por: Chatziralli, Irini P, et al.
Publicado: (2010)

Predictors of hypoglycemia in insulin-treated patients with type 2 diabetes mellitus in Basrah
por: Nassar, Dhuha Tarik, et al.
Publicado: (2016)

Serum aspirin esterase is strongly associated with glucose and lipids in healthy subjects: different association patterns in subjects with type 2 diabetes mellitus
por: Kotani, Kazuhiko, et al.
Publicado: (2010)

Alzheimer's disease and Type 2 diabetes mellitus: the cholinesterase connection?
por: Allam, Appa Rao, et al.
Publicado: (2006)

Minimizing the risk of hypoglycemia in patients with type 2 diabetes mellitus
por: Kushner, Pamela
Publicado: (2010)

NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2
por: Marušić, Marinko, et al.
Publicado: (2021)

An introduction to insulin use in type 2 diabetes mellitus
por: Coetzee, Ankia
Publicado: (2023)

Serum TRAIL levels increase shortly after insulin therapy and metabolic stabilization in children with type 1 diabetes mellitus
por: Tornese, Gianluca, et al.
Publicado: (2015)

Dulaglutide as an Effective Replacement for Prandial Insulin in Kidney Transplant Recipients with Type 2 Diabetes Mellitus: A Retrospective Review
por: Kim, Hwi Seung, et al.
Publicado: (2021)

Initial Sulfonylurea Use and Subsequent Insulin Therapy in Older Subjects with Type 2 Diabetes Mellitus
por: Fu, Alex Z., et al.
Publicado: (2012)

Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes
por: Riddle, Matthew C., et al.
Publicado: (2021)

Current perspective on the role of insulin and glucagon in the pathogenesis and treatment of type 2 diabetes mellitus
por: Ojha, Ashutosh, et al.
Publicado: (2019)

Lower serum chromogranin B level is associated with type 1 diabetes and with type 2 diabetes patients with intensive conservative insulin treatment
por: Herold, Zoltan, et al.
Publicado: (2020)

Regional variations in definitions and rates of hypoglycaemia: findings from the global HAT observational study of 27 585 people with Type 1 and insulin‐treated Type 2 diabetes mellitus
por: Khunti, K., et al.
Publicado: (2018)

Fear of hypoglycemia and its determinants in insulin-treated patients with type 2 diabetes mellitus
por: Sakane, Naoki, et al.
Publicado: (2015)

Self-Monitoring of Blood Glucose in Patients with Insulin-Treated Type 2 Diabetes Mellitus
por: Kim, Kyung-Soo
Publicado: (2018)

Prevalence of asymptomatic bacteriuria in type 2 diabetic subjects with and without microalbuminuria
por: Papazafiropoulou, Athanasia, et al.
Publicado: (2010)

Reduced tricarboxylic acid cycle flux in type 2 diabetes mellitus?
por: Schrauwen, P., et al.
Publicado: (2008)

Peripheral body temperature impairment in individuals with type 1 diabetes mellitus
por: Barone, Mark Thomaz Ugliara, et al.
Publicado: (2018)

The role of selenium in type-2 diabetes mellitus and its metabolic comorbidities
por: Steinbrenner, Holger, et al.
Publicado: (2022)

Undercarboxylated osteocalcin does not correlate with insulin resistance as assessed by euglycemic hyperinsulinemic clamp technique in patients with type 2 diabetes mellitus
por: Mori, Katsuhito, et al.
Publicado: (2012)

Change in DASH diet score and cardiovascular risk factors in youth with type 1 and type 2 diabetes mellitus: The SEARCH for Diabetes in Youth Study
por: Barnes, T L, et al.
Publicado: (2013)

GIP Does Not Potentiate the Antidiabetic Effects of GLP-1 in Hyperglycemic Patients With Type 2 Diabetes
por: Mentis, Nikolaos, et al.
Publicado: (2011)

Professional Continuous Glucose Monitoring for the Identification of Type 1 Diabetes Mellitus Among Subjects With Insulin Therapy
por: Chen, Yin-Chun, et al.
Publicado: (2015)

Association of Plasma Ghrelin Levels with Insulin Resistance in Type 2 Diabetes Mellitus among Saudi Subjects
por: Al Qarni, Ali Ahmed, et al.
Publicado: (2017)

Mechanism of Action of Inhaled Insulin on Whole Body Glucose Metabolism in Subjects with Type 2 Diabetes Mellitus
por: Mehta, Rucha J., et al.
Publicado: (2019)

Linking the Genetics of Type 2 Diabetes With Low Birth Weight: A Role for Prenatal Islet Maldevelopment?
por: Meier, Juris J.
Publicado: (2009)

Insulin Oedema in Newly Diagnosed Type 1 Diabetes Mellitus
por: Baş, Veysel Nijat, et al.
Publicado: (2010)

Insulin: The Friend and the Foe in the Development of Type 2 Diabetes Mellitus
por: Rachdaoui, Nadia
Publicado: (2020)

Role of the inflammasome in insulin resistance and type 2 diabetes mellitus
por: Lu, Shen, et al.
Publicado: (2023)

Ambulatory intravenous insulin and islet cell transplantation to treat severe type III insulin hypersensitivity in a patient with type 1 diabetes mellitus
por: Clarke, Brigette, et al.
Publicado: (2020)

Milder loss of insulin-containing islets in individuals with type 1 diabetes and type 2 diabetes-associated TCF7L2 genetic variants
por: Redondo, Maria J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_od7jmrf7l6sb3j9hkh964l8db0